Home > Publications database > Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions. > print

001     286658
005     20250415112708.0
024 7 _ |a 10.1038/s41467-023-44360-2
|2 doi
024 7 _ |a pmid:38168093
|2 pmid
024 7 _ |a altmetric:157990505
|2 altmetric
037 _ _ |a DKFZ-2024-00022
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Schöpf, Julia
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.
260 _ _ |a [London]
|c 2024
|b Nature Publishing Group UK
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1704372205_31516
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:B290#EA:B340#LA:B290#LA:B340#
520 _ _ |a Linking clinical multi-omics with mechanistic studies may improve the understanding of rare cancers. We leverage two precision oncology programs to investigate rhabdomyosarcoma with FUS/EWSR1-TFCP2 fusions, an orphan malignancy without effective therapies. All tumors exhibit outlier ALK expression, partly accompanied by intragenic deletions and aberrant splicing resulting in ALK variants that are oncogenic and sensitive to ALK inhibitors. Additionally, recurrent CKDN2A/MTAP co-deletions provide a rationale for PRMT5-targeted therapies. Functional studies show that FUS-TFCP2 blocks myogenic differentiation, induces transcription of ALK and truncated TERT, and inhibits DNA repair. Unlike other fusion-driven sarcomas, TFCP2-rearranged tumors exhibit genomic instability and signs of defective homologous recombination. DNA methylation profiling demonstrates a close relationship with undifferentiated sarcomas. In two patients, sarcoma was preceded by benign lesions carrying FUS-TFCP2, indicating stepwise sarcomagenesis. This study illustrates the potential of linking precision oncology with preclinical research to gain insight into the classification, pathogenesis, and therapeutic vulnerabilities of rare cancers.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Uhrig, Sebastian
|0 P:(DE-He78)a8e85c1bd89741ab0c2a28032ba81359
|b 1
|u dkfz
700 1 _ |a Heilig, Christoph
|0 P:(DE-He78)42b6114cd48e033299b2b6ef4bf56cc6
|b 2
|e First author
|u dkfz
700 1 _ |a Lee, Kwang
|0 P:(DE-He78)1121dc6777ecb3a3e48075bbd16246f2
|b 3
|e First author
|u dkfz
700 1 _ |a Walther, Tatjana
|0 P:(DE-He78)e8feda17d03b95bda3e8717e79dc07b8
|b 4
|u dkfz
700 1 _ |a Carazzato, Alexander
|0 P:(DE-He78)0d88f3234ed673d2ed879f28c617cc88
|b 5
700 1 _ |a Dobberkau, Anna
|0 P:(DE-He78)336663951516e6e0e4ac2c7e137f81c4
|b 6
|u dkfz
700 1 _ |a Weichenhan, Dieter
|0 P:(DE-He78)ff4024f7bc236e7897d9c18ee19c451f
|b 7
|u dkfz
700 1 _ |a Plass, Christoph
|0 P:(DE-He78)4301875630bc997edf491c694ae1f8a9
|b 8
|u dkfz
700 1 _ |a Hartmann, Mark
|0 P:(DE-He78)6bd32b26ed14ffc9746ba2d4816e0559
|b 9
|u dkfz
700 1 _ |a Diwan, Gaurav D
|b 10
700 1 _ |a Carrero, Zunamys
|0 P:(DE-He78)e254173fbb1bb21ef535e543ac3c080b
|b 11
700 1 _ |a Ball, Claudia
|0 P:(DE-He78)7a10ea1b9b2872da9f375002c44ddfce
|b 12
|u dkfz
700 1 _ |a Hohl, Tobias
|0 P:(DE-He78)47fc38f9e402b9bc52365aa71af1fa8a
|b 13
700 1 _ |a Kindler, Thomas
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Rudolph-Hähnel, Patricia Serena
|0 P:(DE-He78)3adc05774cba1c87c476ff626d42b4de
|b 15
700 1 _ |a Helm, Dominic
|0 P:(DE-He78)daaed5a5b968028e6e95d273150d5ab1
|b 16
|u dkfz
700 1 _ |a Schneider, Martin
|0 P:(DE-He78)0d37cc734b95fed555f2244d6fee6320
|b 17
|u dkfz
700 1 _ |a Nilsson, Anna
|b 18
700 1 _ |a Øra, Ingrid
|0 0000-0002-3931-4125
|b 19
700 1 _ |a Imle, Roland
|0 P:(DE-He78)3c021852cf94cb29825e65baa82ed54b
|b 20
|u dkfz
700 1 _ |a Banito, Ana
|0 P:(DE-He78)990de6ec6c2f0a40b17ed75162ca19e8
|b 21
|u dkfz
700 1 _ |a Russell, Robert B
|0 0000-0002-1905-4717
|b 22
700 1 _ |a Jones, Barbara
|0 P:(DE-He78)fae1bf941c5fd76cf5356ecfa1243cc4
|b 23
|u dkfz
700 1 _ |a Lipka, Daniel
|0 P:(DE-He78)c403a040c97f91902a7d31b93859f9fc
|b 24
|u dkfz
700 1 _ |a Glimm, Hanno
|0 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9
|b 25
|u dkfz
700 1 _ |a Hübschmann, Daniel
|0 P:(DE-He78)a5218e4871866cd5ab2312e594ca403d
|b 26
|u dkfz
700 1 _ |a Hartmann, Wolfgang
|b 27
700 1 _ |a Fröhling, Stefan
|0 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d
|b 28
|e Last author
|u dkfz
700 1 _ |a Scholl, Claudia
|0 P:(DE-He78)2c1a21d1cf5fdc9e297512c9d1354250
|b 29
|e Last author
|u dkfz
773 _ _ |a 10.1038/s41467-023-44360-2
|g Vol. 15, no. 1, p. 51
|0 PERI:(DE-600)2553671-0
|n 1
|p 51
|t Nature Communications
|v 15
|y 2024
|x 2041-1723
856 4 _ |u https://inrepo02.dkfz.de/record/286658/files/s41467-023-44360-2.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/286658/files/s41467-023-44360-2.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:inrepo02.dkfz.de:286658
|p VDB
|p OpenAPC
|p openCost
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)a8e85c1bd89741ab0c2a28032ba81359
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)42b6114cd48e033299b2b6ef4bf56cc6
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)1121dc6777ecb3a3e48075bbd16246f2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)e8feda17d03b95bda3e8717e79dc07b8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)0d88f3234ed673d2ed879f28c617cc88
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)336663951516e6e0e4ac2c7e137f81c4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)ff4024f7bc236e7897d9c18ee19c451f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)4301875630bc997edf491c694ae1f8a9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)6bd32b26ed14ffc9746ba2d4816e0559
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)e254173fbb1bb21ef535e543ac3c080b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)7a10ea1b9b2872da9f375002c44ddfce
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)47fc38f9e402b9bc52365aa71af1fa8a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)3adc05774cba1c87c476ff626d42b4de
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)daaed5a5b968028e6e95d273150d5ab1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)0d37cc734b95fed555f2244d6fee6320
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)3c021852cf94cb29825e65baa82ed54b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)990de6ec6c2f0a40b17ed75162ca19e8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 23
|6 P:(DE-He78)fae1bf941c5fd76cf5356ecfa1243cc4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 24
|6 P:(DE-He78)c403a040c97f91902a7d31b93859f9fc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 25
|6 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 26
|6 P:(DE-He78)a5218e4871866cd5ab2312e594ca403d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 28
|6 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 29
|6 P:(DE-He78)2c1a21d1cf5fdc9e297512c9d1354250
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2024
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2022
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T09:09:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T09:09:09Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2023-05-02T09:09:09Z
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2023-05-02T09:09:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-29
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2023-08-29
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NAT COMMUN : 2022
|d 2023-08-29
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-08-29
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-08-29
915 p c |a APC keys set
|2 APC
|0 PC:(DE-HGF)0000
915 p c |a Local Funding
|2 APC
|0 PC:(DE-HGF)0001
915 p c |a DFG OA Publikationskosten
|2 APC
|0 PC:(DE-HGF)0002
915 p c |a DOAJ Journal
|2 APC
|0 PC:(DE-HGF)0003
920 2 _ |0 I:(DE-He78)B290-20160331
|k B290
|l Angewandte Funktionelle Genomik
|x 0
920 2 _ |0 I:(DE-He78)B340-20160331
|k B340
|l Translationale Medizinische Onkologie
|x 1
920 0 _ |0 I:(DE-He78)B290-20160331
|k B290
|l Angewandte Funktionelle Genomik
|x 0
920 0 _ |0 I:(DE-He78)B340-20160331
|k B340
|l Translationale Medizinische Onkologie
|x 1
920 1 _ |0 I:(DE-He78)B290-20160331
|k B290
|l Angewandte Funktionelle Genomik
|x 0
920 1 _ |0 I:(DE-He78)B340-20160331
|k B340
|l Translationale Medizinische Onkologie
|x 1
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 2
920 1 _ |0 I:(DE-He78)B370-20160331
|k B370
|l Epigenomik
|x 3
920 1 _ |0 I:(DE-He78)B280-20160331
|k B280
|l B280 Translationale funktionelle Krebsgenomik
|x 4
920 1 _ |0 I:(DE-He78)DD01-20160331
|k DD01
|l DKTK Koordinierungsstelle Dresden
|x 5
920 1 _ |0 I:(DE-He78)FM01-20160331
|k FM01
|l DKTK Koordinierungsstelle Frankfurt
|x 6
920 1 _ |0 I:(DE-He78)W120-20160331
|k W120
|l Proteomics
|x 7
920 1 _ |0 I:(DE-He78)B380-20160331
|k B380
|l NWG Weichteilsarkome
|x 8
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B290-20160331
980 _ _ |a I:(DE-He78)B340-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)B370-20160331
980 _ _ |a I:(DE-He78)B280-20160331
980 _ _ |a I:(DE-He78)DD01-20160331
980 _ _ |a I:(DE-He78)FM01-20160331
980 _ _ |a I:(DE-He78)W120-20160331
980 _ _ |a I:(DE-He78)B380-20160331
980 _ _ |a UNRESTRICTED
980 _ _ |a APC

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21